mRNA vaccine development: Key insights for planning, workflow, and supply chain success
In this report, we will review key insights derived from the
development of mRNA-based COVID-19 vaccines and
how they can be applied to accelerate progress in the
manufacture of mRNA vaccines and therapeutics moving
forward, focusing on the following:• The unique attributes of mRNA vaccine development
• The planning paradigm shift to address major process
challenges and streamline workflow
• Global supply chain implications and the investments and innovations needed to manage them.
Resource Library
Related Sites
Additional Resources
© 2021 Thermo Fisher Scientific Inc. All rights reserved.